22q11.2 Deletion Syndrome
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Human Genomics and Genetic Diseases".
Deadline for manuscript submissions: closed (24 September 2022) | Viewed by 58317
Special Issue Editors
Special Issue Information
Dear Colleagues,
The 22q11.2 deletion syndrome (22q11.2DS) is the most common genomic disorder, with the prevalence of 1 in 2000 to 1 in 4000 livebirths. Despite the well-characterized primary cause of the disease, the variability of the clinical picture is extremely high. More than 180 clinical features, both physical and behavioral, have been described, but no single clinical feature occurs in 100% of cases. Phenotypic variability is a major source of misdiagnosis in patients with 22q11 deletion. Additionally, despite its frequency, this syndrome is still little known among specialists.
Recent extensive research studies have shown the genetic complexity of the syndrome and the influence of other genetic modifiers, apart from deletion of the 22q11 region, on the phenotypic diversity of patients.
This Special Issue will be a collection of both reviews and original research manuscripts, providing an overview of current knowledge on different aspects of diagnostics, treatment, and management of children and adults with the 22q11 deletion syndrome.
Dr. Beata Nowakowska
Prof. Donna M. McDonald-McGinn
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- 22q11 deletion syndrome
- Recurrent deletion
- Variant screening
- Genetic modifiers
- Congenital heart anomalies
- Psychiatric illness
- Immune deficiency
- Next-generation sequencing
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.